The American Medical Association (AMA) has advocated for insurance companies and federal payers to fully cover new obesity treatments, such as Wegovy and Ozempic, despite their high costs. The AMA recognises obesity as a significant health concern and has passed a resolution supporting health insurance coverage for FDA-approved obesity treatments. Medicare currently doesn’t cover weight-loss drugs, and private insurers often view such treatments as non-essential, but change may be on the horizon.
New EU Commission to come up with healthcare cybersecurity plan
The European Commission’s new focus will be strengthening the EU’s healthcare sector against cyber-attacks, with a 100-day plan to initiate implementation of cybersecurity regulations. Cost
